Revolutionizing Memory Care: Sensay Unveils AI-Powered Digital Replicas for Dementia Support and Beyond
[PRESS RELEASE – London, UK, March 11th, 2024] Sensay, a pioneering technology company at the intersection of AI and blockchain, today announced the imminent launch of its innovative platform designed to create autonomous lifelike AI Digital Replicas on-chain, marking a significant leap towards…#aidigitalreplicas #endlesspossibilities #digitaltwins #healthcare #npc #datamarketplace #digitalreplicas #replicas #ethereumnetwork #hashlock (Source: Reuters: Health)
Source: Reuters: Health - March 12, 2024 Category: Consumer Health News Source Type: news
Revolutionizing Memory Care: Sensay Unveils AI-Powered Digital Replicas for Dementia Support and Beyond
London, UK, March 11th, 2024, Chainwire Sensay, a pioneering technology company at the intersection of AI and blockchain, today announced the imminent launch of its innovative platform designed to create autonomous lifelike AI Digital Replicas on-chain, marking a significant leap towards digital…#aidigitalreplicas #endlesspossibilities #digitaltwins #healthcare #npc #datamarketplace #digitalreplicas #replicas #ethereumnetwork #hashlock (Source: Reuters: Health)
Source: Reuters: Health - March 11, 2024 Category: Consumer Health News Source Type: news
Red flag warning sign when you walk could be early dementia symptom
This could appear before memory problems even start, an expert said. (Source: Daily Express - Health)
Source: Daily Express - Health - March 11, 2024 Category: Consumer Health News Source Type: news
'I'm a nutritionist - these are the 3 foods that will slash your risk of dementia'
Each food you choose to "nourish rather than neglect your brain" is an investment in your future well-being, according to a nutritionist. (Source: Daily Express - Health)
Source: Daily Express - Health - March 10, 2024 Category: Consumer Health News Source Type: news
Millions of dementia patients my actually have 'very treatable' liver disease that has been misdiagnosed, according to 'unexpected' study
A new study of US veterans diagnosed with dementia found that many of them had liver disease, suggesting millions of people diagnosed with dementia could actually have a treatable condition. (Source: the Mail online | Health)
Source: the Mail online | Health - March 9, 2024 Category: Consumer Health News Source Type: news
Mild Cognitive Impairment: What Can We Do in Primary Care? Mild Cognitive Impairment: What Can We Do in Primary Care?
Biomarkers, expanded disease definitions, and new drugs could change the approach to mild cognitive impairment and dementia among older patients.Medscape Family Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 8, 2024 Category: Consumer Health News Tags: Family Medicine/Primary Care Commentary Source Type: news
AAN: Dementia More Common With Essential Tremor Than in the General Population
FRIDAY, March 8, 2024 -- Dementia rates are substantially higher among people with essential tremor than the general population, according to a study scheduled for presentation at the annual meeting of the American Academy of Neurology, to be held... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 8, 2024 Category: Pharmaceuticals Source Type: news
Tremor Could Point to Higher Odds for Dementia
FRIDAY, March 8, 2024 -- Dementia could three times more common among people suffering from essential tremor, a movement disorder that causes involuntary shaking, a new study suggests. “Not only do tremors affect a person’s ability to complete... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 8, 2024 Category: General Medicine Source Type: news
Experts warn a noticable change in someone's mood could be an early sign of dementia
According to the NHS, it is estimated that around 676,000 people in England have the disease. (Source: Daily Express - Health)
Source: Daily Express - Health - March 8, 2024 Category: Consumer Health News Source Type: news
Whose house is it, anyway? The growing problem of inheritance
With ageing populations and dementia rates rising fast, the family home — worth more than ever before — is increasingly the focus of discord (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - March 8, 2024 Category: Pharmaceuticals Source Type: news
Dementia More Common in People With Essential Tremor
(MedPage Today) -- Dementia was more common in people with essential tremor than in the general population, a prospective cohort study found.
Over 5 years, the cumulative prevalence of dementia was 18.5% and the average annual conversion rate... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - March 6, 2024 Category: Neurology Source Type: news
Lucid Moments in Late Dementia; Seizure Dogs and Epilepsy; Wildfire Smoke Effects
(MedPage Today) -- Researchers characterized lucid episodes among people with late-stage Alzheimer's disease and related dementias. (Alzheimer's & Dementia)
Seizure dogs reduced seizure frequency in adults with medically refractory epilepsy... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - March 5, 2024 Category: Neurology Source Type: news
AI May Help Predict Mortality in Dementia Patients
TUESDAY, March 5, 2024 -- Artificial intelligence models may enable the flagging of dementia patients at risk for mortality, according to a study published online Feb. 28 in Communications Medicine.
Jimmy Zhang, M.D., from the Icahn School of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 5, 2024 Category: Pharmaceuticals Source Type: news
Roche and Alnylam report positive topline results from the Phase II KARDIA-2 study in people with hypertension, demonstrating clinically significant blood pressure reductions with zilebesiran when added to standard of care
KARDIA-2 study met its primary endpoint, demonstrating clinically significant systolic blood pressure reductions in each treatment arm at month threeZilebesiran added to a standard of care hypertension medication demonstrated an encouraging safety and tolerability profile in adults with mild to moderate uncontrolled hypertension, and results support the potential for twice-yearly dosingRoche and Alnylam have initiated the Phase II KARDIA-3 study in adults with uncontrolled hypertension at high cardiovascular riskKARDIA-2 study results will be presented as a late-breaking abstract in April at the 2024 American College of Ca...
Source: Roche Investor Update - March 5, 2024 Category: Pharmaceuticals Source Type: news
Roche and Alnylam report positive topline results from the Phase II KARDIA-2 study in people with hypertension, demonstrating clinically significant blood pressure reductions with zilebesiran when added to standard of care
KARDIA-2 study met its primary endpoint, demonstrating clinically significant systolic blood pressure reductions in each treatment arm at month threeZilebesiran added to a standard of care hypertension medication demonstrated an encouraging safety and tolerability profile in adults with mild to moderate uncontrolled hypertension, and results support the potential for twice-yearly dosingRoche and Alnylam have initiated the Phase II KARDIA-3 study in adults with uncontrolled hypertension at high cardiovascular riskKARDIA-2 study results will be presented as a late-breaking abstract in April at the 2024 American College of Ca...
Source: Roche Media News - March 5, 2024 Category: Pharmaceuticals Source Type: news
